Skip to content

A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free Home

Freedom to Breathe: Pilot Study Towards Achieving Environmental Justice for Cancer Patients and Their Families

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06693700
Enrollment
10
Registered
2024-11-18
Start date
2024-11-14
Completion date
2027-11-14
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking, Smoking Behaviors, Smoking Cessation, Smoking, Cigarette, Smoking Habit, Smoking Reduction, Smoking, Tobacco, Smoking (Tobacco) Addiction, Tobacco Smoking, Tobacco Use

Keywords

smoking, smoking cessation, smoking reduction, smoking habit, smoking behaviors, smoking, tobacco, smoking, cigarette, smoking (tobacco) addiction, tobacco use, tobacco smoking, air quality, indoor air quality monitoring devices, 24-260, Memorial Sloan Kettering Cancer Center

Brief summary

The purpose of this study is to evaluate how using an indoor air quality monitor can promote a smoke-free home for cancer patients who are enrolled in MSK's Tobacco Treatment Program.

Interventions

OTHERIndoor Air Quality Monitor AirGradient ONE

Participants will be asked to set up an Indoor Air Quality Monitor AirGradient ONE (Model: I-9PSL) which is an award winning commercially available indoor air quality monitor designed to enable anyone to monitor their air quality in their home for about 60 days (8 weeks). Indoor air pollution levels within participating households will be measured using these AQMs.

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult (aged \>18 years) MSK patients as per the EHR * Has been referred and enrolled in the MSK TTP and completed the initial counseling session as per the TTP clinical database * Reports current (within the past 30 days) tobacco use (i.e., cigarettes and/or any other tobacco products) as per the TTP Intake form * Must be English-speaking in the EHR * Must be reachable by phone as per self-report * Must have Wi-Fi available at home as per self-report

Exclusion criteria

* Patient reports that no smoking is allowed, by them or anyone else, in the home as per the TTP intake form and/or per self-report

Design outcomes

Primary

MeasureTime frameDescription
Percentage of participants using the air quality monitoring device for 14 consecutive daysup to 8 weeksAssess the feasibility and acceptability of collecting environmental data on biomarkers of household air quality (AQ) and smoke exposure using low-cost, AQMs as an intermediate endpoint of a smoke-free-home.
Percentage of participants who attend the study-specific smoke-free workshop sessionsUp to 8 weeksAssess the feasibility and acceptability of tobacco treatment adherence among individuals diagnosed with cancer.

Countries

United States

Contacts

CONTACTGleneara Bates-Pappas, PhD, LMSW
batespag@mskcc.org212-610-0507
CONTACTMichael Bellamy, PhD
bellamym@mskcc.org212-639-2045
PRINCIPAL_INVESTIGATORGleneara Bates-Pappas, PhD, LMSW

Memorial Sloan Kettering Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026